114 related articles for article (PubMed ID: 26306547)
1. Rasch-Transformed Total Neuropathy Score clinical version (RT-TNSc(©) ) in patients with chemotherapy-induced peripheral neuropathy.
Binda D; Cavaletti G; Cornblath DR; Merkies IS;
J Peripher Nerv Syst; 2015 Sep; 20(3):328-32. PubMed ID: 26306547
[TBL] [Abstract][Full Text] [Related]
2. Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS).
Binda D; Vanhoutte EK; Cavaletti G; Cornblath DR; Postma TJ; Frigeni B; Alberti P; Bruna J; Velasco R; Argyriou AA; Kalofonos HP; Psimaras D; Ricard D; Pace A; Galiè E; Briani C; Dalla Torre C; Lalisang RI; Boogerd W; Brandsma D; Koeppen S; Hense J; Storey D; Kerrigan S; Schenone A; Fabbri S; Rossi E; Valsecchi MG; Faber CG; Merkies IS; ; Galimberti S; Lanzani F; Mattavelli L; Piatti ML; Bidoli P; Cazzaniga M; Cortinovis D; Lucchetta M; Campagnolo M; Bakkers M; Brouwer B; Boogerd W; Grant R; Reni L; Piras B; Pessino A; Padua L; Granata G; Leandri M; Ghignotti I; Plasmati R; Pastorelli F; Heimans JJ; Eurelings M; Meijer RJ; Grisold W; Lindeck Pozza E; Mazzeo A; Toscano A; Russo M; Tomasello C; Altavilla G; Penas Prado M; Dominguez Gonzalez C; Dorsey SG
Eur J Cancer; 2013 Sep; 49(13):2910-8. PubMed ID: 23668917
[TBL] [Abstract][Full Text] [Related]
3. Improving assessment in small fiber neuropathy.
Brouwer BA; Bakkers M; Hoeijmakers JG; Faber CG; Merkies IS
J Peripher Nerv Syst; 2015 Sep; 20(3):333-40. PubMed ID: 26114213
[TBL] [Abstract][Full Text] [Related]
4. The Total Neuropathy Score as an assessment tool for grading the course of chemotherapy-induced peripheral neurotoxicity: comparison with the National Cancer Institute-Common Toxicity Scale.
Cavaletti G; Frigeni B; Lanzani F; Piatti M; Rota S; Briani C; Zara G; Plasmati R; Pastorelli F; Caraceni A; Pace A; Manicone M; Lissoni A; Colombo N; Bianchi G; Zanna C;
J Peripher Nerv Syst; 2007 Sep; 12(3):210-5. PubMed ID: 17868248
[TBL] [Abstract][Full Text] [Related]
5. Prospective Evaluation of Health Care Provider and Patient Assessments in Chemotherapy-Induced Peripheral Neurotoxicity.
Alberti P; Bernasconi DP; Cornblath DR; Merkies ISJ; Park SB; Velasco R; Bruna J; Psimaras D; Koeppen S; Pace A; Dorsey SG; Argyriou AA; Kalofonos HP; Briani C; Schenone A; Faber CG; Mazzeo A; Grisold W; Valsecchi M; Cavaletti G;
Neurology; 2021 Aug; 97(7):e660-e672. PubMed ID: 34078718
[TBL] [Abstract][Full Text] [Related]
6. Multi-center assessment of the Total Neuropathy Score for chemotherapy-induced peripheral neurotoxicity.
Cavaletti G; Jann S; Pace A; Plasmati R; Siciliano G; Briani C; Cocito D; Padua L; Ghiglione E; Manicone M; Giussani G;
J Peripher Nerv Syst; 2006 Jun; 11(2):135-41. PubMed ID: 16787511
[TBL] [Abstract][Full Text] [Related]
7. In Search of a Gold Standard Patient-Reported Outcome Measure for Use in Chemotherapy- Induced Peripheral Neuropathy Clinical Trials.
Smith EML; Knoerl R; Yang JJ; Kanzawa-Lee G; Lee D; Bridges CM
Cancer Control; 2018; 25(1):1073274818756608. PubMed ID: 29480026
[TBL] [Abstract][Full Text] [Related]
8. Lenalidomide in patients with chemotherapy-induced polyneuropathy and relapsed or refractory multiple myeloma: results from a single-centre prospective study.
Briani C; Torre CD; Campagnolo M; Lucchetta M; Berno T; Candiotto L; Padua L; Ermani M; Cavaletti G; Zambello R
J Peripher Nerv Syst; 2013 Mar; 18(1):19-24. PubMed ID: 23521639
[TBL] [Abstract][Full Text] [Related]
9. Rasch model-based testing of the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire-Chemotherapy-Induced Peripheral Neuropathy (QLQ-CIPN20) using Alliance for Clinical Trials in Oncology (Alliance) A151408 study data.
Smith EML; Zanville N; Kanzawa-Lee G; Donohoe C; Bridges C; Loprinzi C; Le-Rademacher J; Yang JJ
Support Care Cancer; 2019 Jul; 27(7):2599-2608. PubMed ID: 30460399
[TBL] [Abstract][Full Text] [Related]
10. Oxaliplatin-Induced Peripheral Neuropathy and Identification of Unique Severity Groups in Colorectal Cancer.
Griffith KA; Zhu S; Johantgen M; Kessler MD; Renn C; Beutler AS; Kanwar R; Ambulos N; Cavaletti G; Bruna J; Briani C; Argyriou AA; Kalofonos HP; Yerges-Armstrong LM; Dorsey SG
J Pain Symptom Manage; 2017 Nov; 54(5):701-706.e1. PubMed ID: 28743660
[TBL] [Abstract][Full Text] [Related]
11. Assessing risk factors of falls in cancer patients with chemotherapy-induced peripheral neurotoxicity.
Argyriou AA; Bruna J; Anastopoulou GG; Velasco R; Litsardopoulos P; Kalofonos HP
Support Care Cancer; 2020 Apr; 28(4):1991-1995. PubMed ID: 31378844
[TBL] [Abstract][Full Text] [Related]
12. Painful Diabetic Neuropathy Anxiety Rasch-Transformed Questionnaire (PART-Q30(©) ).
Geelen CC; Brouwer BA; Hoeijmakers JG; Faber CG; Merkies IS; Verbunt JA
J Peripher Nerv Syst; 2016 Jun; 21(2):96-104. PubMed ID: 26840031
[TBL] [Abstract][Full Text] [Related]
13. Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin.
Alberti P; Rossi E; Cornblath DR; Merkies IS; Postma TJ; Frigeni B; Bruna J; Velasco R; Argyriou AA; Kalofonos HP; Psimaras D; Ricard D; Pace A; Galiè E; Briani C; Dalla Torre C; Faber CG; Lalisang RI; Boogerd W; Brandsma D; Koeppen S; Hense J; Storey D; Kerrigan S; Schenone A; Fabbri S; Valsecchi MG; Cavaletti G;
Ann Oncol; 2014 Jan; 25(1):257-64. PubMed ID: 24256846
[TBL] [Abstract][Full Text] [Related]
14. Quick, non-invasive and quantitative assessment of small fiber neuropathy in patients receiving chemotherapy.
Saad M; Psimaras D; Tafani C; Sallansonnet-Froment M; Calvet JH; Vilier A; Tigaud JM; Bompaire F; Lebouteux M; de Greslan T; Ceccaldi B; Poirier JM; Ferrand FR; Le Moulec S; Huillard O; Goldwasser F; Taillia H; Maisonobe T; Ricard D
J Neurooncol; 2016 Apr; 127(2):373-80. PubMed ID: 26749101
[TBL] [Abstract][Full Text] [Related]
15. The reliability and validity of a modified total neuropathy score-reduced and neuropathic pain severity items when used to measure chemotherapy-induced peripheral neuropathy in patients receiving taxanes and platinums.
Smith EM; Cohen JA; Pett MA; Beck SL
Cancer Nurs; 2010; 33(3):173-83. PubMed ID: 20357656
[TBL] [Abstract][Full Text] [Related]
16. The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings.
Cavaletti G; Cornblath DR; Merkies ISJ; Postma TJ; Rossi E; Frigeni B; Alberti P; Bruna J; Velasco R; Argyriou AA; Kalofonos HP; Psimaras D; Ricard D; Pace A; Galiè E; Briani C; Dalla Torre C; Faber CG; Lalisang RI; Boogerd W; Brandsma D; Koeppen S; Hense J; Storey D; Kerrigan S; Schenone A; Fabbri S; Valsecchi MG; ; Mazzeo A; Pace A; Pessino A; Schenone A; Toscano A; Argyriou AA; Brouwer B; Frigeni B; Piras B; Briani C; Dalla Torre C; Dominguez Gonzalez C; Faber CG; Tomasello C; Binda D; Brandsma D; Cortinovis D; Psimaras D; Ricard D; Storey D; Cornblath DR; Galiè E; Lindeck Pozza E; Rossi E; Vanhoutte EK; Lanzani F; Pastorelli F; Altavilla G; Cavaletti G; Granata G; Kalofonos HP; Ghignotti I; Merkies ISJ; Bruna J; Hense J; Heimans JJ; Mattavelli L; Padua L; Reni L; Bakkers M; Boogerd M; Campagnolo M; Cazzaniga M; Eurelings M; Leandri M; Lucchetta M; Penas Prado M; Russo M; Valsecchi MG; Piatti ML; Alberti P; Bidoli P; Grant R; Plasmati R; Velasco R; Lalisang RI; Meijer RJ; Fabbri S; Dorsey SG; Galimberti S; Kerrigan S; Koeppen S; Postma TJ; Boogerd W; Grisold W
Ann Oncol; 2013 Feb; 24(2):454-462. PubMed ID: 22910842
[TBL] [Abstract][Full Text] [Related]
17. The Val30Met familial amyloid polyneuropathy specific Rasch-built overall disability scale (FAP-RODS(©) ).
Pruppers MH; Merkies IS; Faber CG; Da Silva AM; Costa V; Coelho T
J Peripher Nerv Syst; 2015 Sep; 20(3):319-27. PubMed ID: 26115039
[TBL] [Abstract][Full Text] [Related]
18. A prospective surveillance model for physical rehabilitation of women with breast cancer: chemotherapy-induced peripheral neuropathy.
Stubblefield MD; McNeely ML; Alfano CM; Mayer DK
Cancer; 2012 Apr; 118(8 Suppl):2250-60. PubMed ID: 22488699
[TBL] [Abstract][Full Text] [Related]
19. Sensorimotor training and whole-body vibration training have the potential to reduce motor and sensory symptoms of chemotherapy-induced peripheral neuropathy-a randomized controlled pilot trial.
Streckmann F; Lehmann HC; Balke M; Schenk A; Oberste M; Heller A; Schürhörster A; Elter T; Bloch W; Baumann FT
Support Care Cancer; 2019 Jul; 27(7):2471-2478. PubMed ID: 30382392
[TBL] [Abstract][Full Text] [Related]
20. Long-term course of oxaliplatin-induced polyneuropathy: a prospective 2-year follow-up study.
Briani C; Argyriou AA; Izquierdo C; Velasco R; Campagnolo M; Alberti P; Frigeni B; Cacciavillani M; Bergamo F; Cortinovis D; Cazzaniga M; Bruna J; Cavaletti G; Kalofonos HP
J Peripher Nerv Syst; 2014 Dec; 19(4):299-306. PubMed ID: 25582667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
